miR-26a enhances miRNA biogenesis by targeting Lin28B and Zcchc11 to suppress tumor growth and metastasis

X Fu1, Z Meng2, W Liang3

  • 1Division of Molecular Diabetes Research, Department of Diabetes and Metabolic Diseases Research, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA, USA.

Oncogene
|September 24, 2013
PubMed

Insights

MicroRNA-26a (miR-26a) enhances microRNA biogenesis, suppressing tumor growth and metastasis in cancers like melanoma, prostate, and liver cancer. It targets repressors of let-7 maturation, offering a new cancer therapy strategy.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • Human cancers often show reduced microRNA (miRNA) levels, suggesting miRNA biogenesis pathways are potential therapeutic targets.
  • Restoring miRNA expression is a promising strategy for cancer treatment.

Purpose of the Study:

  • To investigate the role of miR-26a in miRNA biogenesis and its impact on cancer progression.
  • To identify the molecular mechanisms underlying miR-26a's tumor-suppressive functions.

Main Methods:

  • Analysis of miRNA expression in various human cancers.
  • Overexpression of miR-26a in cancer cell lines and in vivo models (melanoma, prostate, liver cancer).
  • Luciferase assays to confirm direct targeting of Lin28B and Zcchc11 by miR-26a.

Main Results:

  • miR-26a expression is reduced in multiple human cancers.
  • Overexpression of miR-26a suppressed tumor growth and metastasis and led to global miRNA upregulation, particularly let-7.
  • miR-26a directly targets and inhibits Lin28B and Zcchc11, key repressors of let-7 maturation.
  • Zcchc11 was found to promote tumor growth and metastasis and was overexpressed in human cancers.

Conclusions:

  • miR-26a enhances miRNA biogenesis by targeting Lin28B and Zcchc11, thereby suppressing tumor growth and metastasis.
  • This study reveals a novel mechanism of miRNA-mediated regulation of miRNA biogenesis.
  • The miR-26a/Lin28B/Zcchc11 axis represents a potential therapeutic target for various cancers.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...